Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:BUX)

BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection

Newsfile November 5, 2024

BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN

Newsfile September 24, 2024

BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection

Newsfile September 10, 2024

Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright's 26th Annual Global Investment Conference in New York

Newsfile August 26, 2024

The U.S. Patent and Trademark Office Grants BioMark Patent That Expands Its Claims Covering Its Legacy Liquid Biopsy Assay

Newsfile July 31, 2024

BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research at 2024 GPEN Conference

Newsfile July 15, 2024

BioMark Announces Warrant Extension and Granting of Options

Newsfile April 18, 2024

BioMark to Advance Development of Cancer Treatment for Glioblastoma

Newsfile April 9, 2024

BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities

Newsfile February 28, 2024
View More News ››

Opinion & Analysis (CSE:BUX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:BUX)

I just pre-refreshed my order

which for some reason just doesn't show as a viable buy, at least on SH. I see Bux and Huang are ponying up a little more, almost...
geodcan - July 15, 2024

RE:If the insiders quit manipulating the sp

Yes, 100% agree. At this stage, I peg the fair value at about .10 to .15 cents. So difficult to confirm with the share price management...
David8888 - July 12, 2024

If the insiders quit manipulating the sp

we would get a fairer asessment  of the real value of this company. Might motivate management to do something more businesslike to...
geodcan - July 11, 2024

No bid on Stockhouse site

and yet I have been on the bid for about a year for an order that will cost me thousands if the artificial support by managment stops...
geodcan - July 10, 2024

No bid on Stockhouse site

and yet I have been on the bid for about a year for an order that will cost me thousands if the artificial support by managment stops...
geodcan - July 10, 2024

What Changed

Interesting. This has moved from .30 range to now the .20 range. Insider propping this up has slowed.
David8888 - July 5, 2024
View more Bullboard ››

Goldflare Exploration Inc

Goldflare Exploration Inc

Goldflare Exploration Inc. is a mineral exploration company. The Company specializes in gold exploration in the province of ...
View More »